You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Myeloma (Kahler's disease)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

Not yet recruiting
  • Multiple Myeloma
  • Minimal Residual Disease
    • (no location specified)
    Nov 1, 2023

    Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

    Not yet recruiting
    • Multiple Myeloma
    • Smoldering Multiple Myeloma
    • TG01
    • Oslo, Norway
      Oslo Myeloma Center
    May 2, 2023

    Using Mass Spectrometry Detecting Minimal Residual Disease in

    Recruiting
    • Multiple Myeloma
      • Tianjin, China
        InsituteHBDH
      Sep 8, 2022

      Multiple Myeloma Trial (Continued treatment adapted to the response)

      Completed
      • Multiple Myeloma
      • Continued treatment adapted to the response
      • (no location specified)
      Jan 14, 2023

      Multiple Myeloma Minimal Residual Disease

      Completed
      • Multiple Myeloma
      • blood samples and bone marrow aspirates will be collected
      • Lille, France
      • +2 more
      Sep 2, 2022

      Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Changzhou, Jiangsu, China
      • +5 more
      Jun 11, 2023

      Non-invasive MRD Assessment in Multiple Myeloma

      Recruiting
      • Myeloma
      • MRD Assessment
      • New York, New York
        New York Presbyterian Hospital/Columbia University Irving Medica
      Nov 15, 2022

      Plasma Cell Myeloma Trial in Buffalo (Belantamab Mafodotin, Lenalidomide)

      Recruiting
      • Plasma Cell Myeloma
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 5, 2022

      Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

      Not yet recruiting
      • Cancer Prevention
      • +5 more
      • Prolonged Fasting Intervention
      • EDUCATION CONTROL
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 28, 2022

      Multiple Myeloma, Osteoporosis Trial in United States (Romosozumab)

      Recruiting
      • Multiple Myeloma
      • Osteoporosis
      • Basking Ridge, New Jersey
      • +6 more
      Mar 7, 2023

      ctDNA Methylation Sequencing for Myeloma

      Recruiting
      • Multiple Myeloma
      • plasma circulation DNA methylation sequencing
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      Oct 11, 2022

      Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or

      Recruiting
      • Advanced Solid Tumor
      • +2 more
      • Barcelona, Spain
      • +4 more
      Dec 19, 2022

      Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

      Recruiting
      • Gaucher Disease
      • Acid SphingoMyelinase Deficiency
        • Ponferrada, León, Spain
        • +11 more
        Aug 8, 2023

        Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

        Recruiting
        • Multiple Myeloma
        • Ann Arbor, Michigan
        • +3 more
        Jan 19, 2023

        Multiple Myeloma Trial in Odense C (Zoledronic acid)

        Active, not recruiting
        • Multiple Myeloma
        • Zoledronic acid
        • Odense C, Denmark
          Odense University Hospital
        Apr 20, 2022

        Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

        Active, not recruiting
        • Multiple Myeloma
        • +4 more
        • Total Body Irradiation
        • +5 more
        • Los Angeles, California
          Cedars Sinai Medical Center
        Dec 21, 2022

        Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

        Not yet recruiting
        • Multiple Myeloma
        • +4 more
        • (no location specified)
        Nov 29, 2022

        Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

        Recruiting
        • Relapsed/Refractory Multiple Myeloma
        • Kashiwa-shi, Chiba, Japan
        • +5 more
        Jan 25, 2023

        Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

        Not yet recruiting
        • Multiple Myeloma
        • +7 more
        • Belantamab Mafodotin-Blmf
        • +3 more
        • (no location specified)
        Oct 11, 2022

        Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

        Recruiting
        • Multiple Myeloma
        • Saint Louis, Missouri
          Washington University School of Medicine
        Apr 4, 2022

        Multiple Myeloma Trial (Isatuximab, Lenalidomide)

        Not yet recruiting
        • Multiple Myeloma
        • (no location specified)
        Apr 19, 2022

        Myeloma Multiple Trial in Orange, Nashville (Descartes 08)

        Recruiting
        • Myeloma Multiple
        • Descartes 08
        • Orange, California
        • +1 more
        Apr 4, 2022